Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusion

In summary, first time abciximab administration was associated with acute profound thrombocytopenia in 4 of 575 consecutive patients. Therapy with platelet transfusion is associated with a rapid and sustained increment in circulating platelet count and clinical hemostasis.